Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.36K Hold
20
﹤0.01% 997
2026
Q1
$2.39K Buy
+20
New +$2.62K ﹤0.01% 744
2025
Q2
Sell
-53
Closed -$6.33K 881
2025
Q1
$6.33K Hold
53
﹤0.01% 646
2024
Q4
$6.15K Sell
53
-41
-44% -$5.18K ﹤0.01% 652
2024
Q3
$12.7K Sell
94
-47
-33% -$6.29K ﹤0.01% 580
2024
Q2
$19.1K Sell
141
-17
-11% -$2.31K 0.01% 511
2024
Q1
$20.4K Sell
158
-388
-71% -$46.9K 0.01% 537
2023
Q4
$62.4K Sell
546
-33
-6% -$3.29K 0.02% 391
2023
Q3
$52.7K Hold
579
0.02% 466
2023
Q2
$65.2K Hold
579
0.02% 443
2023
Q1
$60.6K Sell
579
-86
-13% -$8.98K 0.02% 453
2022
Q4
$74K Buy
+665
New +$69.7K 0.02% 419

Other funds holding XYL

Park Place Capital's XYL Position: Q2 2026 in Review

Park Place Capital held its Xylem (XYL) position steady in Q2 2026 at 20 shares worth $2.36K. The position accounts for ﹤0.01% of the portfolio, ranked #997.

Park Place Capital first reported a position in XYL in Q4 2022 and has held it in 12 quarters since. The position peaked at $74K in Q4 2022. 1,090 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Park Place Capital held 20 shares of Xylem worth $2.36K as of Q2 2026.
  • Park Place Capital left its Xylem share count unchanged in Q2 2026.
  • Xylem made up ﹤0.01% of Park Place Capital's portfolio in Q2 2026, its #997 holding.
  • Park Place Capital first reported a position in Xylem in Q4 2022 and has held it in 12 quarters since.
  • Park Place Capital's Xylem position peaked at $74K in Q4 2022.
  • 1,090 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.